A Clinical study on Sivakaranthai Ilai Chooranam in the management of Cegana Vatham (Cervical spondylosis)

A Prospective open labelled non randomised phase II clinical study of Sivakaranthai Ilai Chooranam in the management of Cegana Vatham (Cervical spondylosis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023675

Enrollment

Registered

2020-03-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M501- Cervical disc disorder with radiculopathy

Interventions

Intervention1: Sivakaranthai Ilai Chooranam: 40 mg/kg/BW/twice a day A/F 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1)Neck pain radiating to upper limb with or without numbness,giddiness and neck stiffness. 2)Restriction neck movements. 3)Willing for doing x-ray imaging. 4)Neck disability index score should be equal or greater than 40%.

Exclusion criteria

Exclusion criteria: 1)Traumatic injury 2)Thyrotoxicosis 3)Tuberculosis in spine 4)Ischemic heart disease 5)Polymyositis 6)Bony metastasis 7)Congenital spinal anomalies

Design outcomes

Primary

Measure	Time frame
1.Reduction of pain in neck and upper limbs 2.Improvement of the range of movements in the neck and upper limbsTimepoint: 45 days	—

Secondary

Measure	Time frame
1.Evaluation of pharmacological,biochemical and phytochemical analysis of trial drug. 2.Determination of safety profile of trial drug. 3.Evaluation of additional effects and siddha parameters changes in Cegana VathamTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDrSJustus Antony MD PhD

Government Siddha Medical College and Hospital

justusantony71@gmail.com9443090849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026